KR100567717B1 - 알파-글루코시다제 및 알파-아밀라제 억제제를 함유하는영양 보충제 - Google Patents
알파-글루코시다제 및 알파-아밀라제 억제제를 함유하는영양 보충제 Download PDFInfo
- Publication number
- KR100567717B1 KR100567717B1 KR1020030078232A KR20030078232A KR100567717B1 KR 100567717 B1 KR100567717 B1 KR 100567717B1 KR 1020030078232 A KR1020030078232 A KR 1020030078232A KR 20030078232 A KR20030078232 A KR 20030078232A KR 100567717 B1 KR100567717 B1 KR 100567717B1
- Authority
- KR
- South Korea
- Prior art keywords
- nutritional supplement
- alpha
- supplement composition
- weight
- extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
성분 | 양 (mg) | 총 조성물 중의 중량% |
규화된 미세결정 셀룰로스 | 215 | 40.71 |
타우치(touchi) 추출물 | 100 | 18.93 |
개질된 셀룰로스 검 (크로스카멜로스 소듐(croscarmellose sodium)), 정제 붕해제 | 12.5 | 2.37 |
파세올라민(phaseolamin) | 166.67 | 31.56 |
스테아르산 | 20 | 3.79 |
이산화규소 | 4 | 0.76 |
유기 파슬리 | 10 | 1.89 |
타우치에 의한 차단능 (Kcal) | 파세올라민에 의한 차단능 (Kcal) | 1 g 조성물의 총 차단능 (Kcal) | |
1000 mg 조성물 | 37.8 | 820.8 | 858.6 Kcal |
190 mg 타우치 추출물 | 22.15 | 0 | |
320 mg 파세올라민 추출물 | 0 | 497.7 | |
두 성분의 개별 작용시 총 차단량 (Kcal) | |||
22.15 | 497.7 | 519.85 Kcal | |
총 차단량 (Kcal)의 차이; 제형 대 단독의 개별 성분들 | 338.75 Kcal | ||
(개선율 (%)) | 65% |
Claims (29)
- 7 내지 35 중량%의 타우치 추출물, 15 내지 48 중량%의 파세올라민 및 허용가능한 담체를 포함하고, 0.001 중량% 미만의 리파제 억제제를 포함하는 영양 보충 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 제1항에 있어서, 상기 타우치 추출물이 영양 보충 조성물의 13 내지 27 중량%를 차지하는 영양 보충 조성물.
- 제1항에 있어서, 상기 타우치 추출물이 영양 보충 조성물의 18 내지 19 중량%를 차지하는 영양 보충 조성물.
- 삭제
- 제1항에 있어서, 상기 파세올라민이 영양 보충 조성물의 24 내지 40 중량%를 차지하는 영양 보충 조성물.
- 제1항에 있어서, 상기 파세올라민이 영양 보충 조성물의 31 내지 32 중량%를 차지하는 영양 보충 조성물.
- 제1항에 있어서, 상기 타우치 추출물이 영양 보충 조성물의 18 내지 19 중량%를 차지하고, 상기 파세올라민이 영양 보충 조성물의 31 내지 32 중량%를 차지하는 영양 보충 조성물.
- 개별적으로 10 내지 3000 mg의 타우치 추출물 및 70 내지 4500 mg의 파세올라민, 및 허용가능한 담체를 포함하는 고체 투여량 단위를 포함하고, 0.001 중량% 미만의 리파제 억제제를 포함하며, 상기 고체 투여량 단위의 총 중량이 80 내지 7500 mg인 영양 보충 조성물.
- 제12항에 있어서, 80 내지 120 mg의 타우치 추출물 및 150 내지 175 mg의 파세올라민을 개별적으로 포함하는 고체 투여량 단위를 포함하는 영양 보충 조성물.
- 제12항에 있어서, 100 mg의 타우치 추출물 및 166.67 mg의 파세올라민을 개별적으로 포함하는 고체 투여량 단위를 포함하는 영양 보충 조성물.
- 제1항에 있어서, 구풍제(carminative)를 추가로 포함하는 영양 보충 조성물.
- 제15항에 있어서, 상기 구풍제가 파슬리를 포함하는 영양 보충 조성물.
- 7 내지 35 중량%의 타우치 추출물 및 15 내지 48 중량%의 파세올라민을 포함하고, 0.001 중량% 미만의 리파제 억제제를 포함하는, 탄수화물의 흡수 제한용 영양 보충 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 7 내지 35 중량%의 타우치 추출물 및 15 내지 48 중량%의 파세올라민을 포함하고, 0.001 중량% 미만의 리파제 억제제를 포함하는, 개인의 체중 감량 촉진용 영양 보충 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 제1항에 있어서, 상기 타우치 추출물이 영양 보충 조성물의 7 내지 11 중량%를 차지하는 영양 보충 조성물.
- 제1항에 있어서, 상기 파세올라민이 영양 보충 조성물의 15 내지 19 중량%를 차지하는 영양 보충 조성물.
- 제12항에 있어서, 50 내지 75 mg의 타우치 추출물 및 100 내지 125 mg의 파세올라민을 개별적으로 포함하는 고체 투여량 단위를 포함하는 영양 보충 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/290,079 US7108869B2 (en) | 2002-11-07 | 2002-11-07 | Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
US10/290,079 | 2002-11-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040041026A KR20040041026A (ko) | 2004-05-13 |
KR100567717B1 true KR100567717B1 (ko) | 2006-04-05 |
Family
ID=32228988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030078232A KR100567717B1 (ko) | 2002-11-07 | 2003-11-06 | 알파-글루코시다제 및 알파-아밀라제 억제제를 함유하는영양 보충제 |
Country Status (4)
Country | Link |
---|---|
US (2) | US7108869B2 (ko) |
JP (1) | JP3793764B2 (ko) |
KR (1) | KR100567717B1 (ko) |
CN (1) | CN100352504C (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713546B1 (en) * | 2001-04-03 | 2010-05-11 | Soft Gel Technologies, Inc. | Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
US20050181044A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract |
US20060051435A1 (en) * | 2004-08-19 | 2006-03-09 | Udell Ronald G | Nutritional supplement for body fat reduction |
CN100349614C (zh) * | 2005-10-21 | 2007-11-21 | 南京工业大学 | 一种含α-淀粉酶抑制剂的固体混合物及其制备工艺和在制药中的应用 |
MY147954A (en) * | 2006-05-26 | 2013-02-15 | Nestec Sa | Methods of use and nutritional compositions of touchi extract |
JP2009249315A (ja) | 2008-04-03 | 2009-10-29 | Fujifilm Corp | ミネラル吸収促進剤ならびに鉄欠乏性貧血改善剤または食品組成物 |
US20100029581A1 (en) * | 2008-07-31 | 2010-02-04 | Ramandeep Kaur Dhillon-Gill | Nutritional supplement |
SG174540A1 (en) * | 2009-03-26 | 2011-10-28 | Biofermin Pharmaceutical Co Ltd | Agent for enhancing hypoglycemic activity |
EP2493489A4 (en) * | 2009-10-26 | 2013-05-22 | Pharmachem Lab Inc | METHOD OF TREATING ACIDOSIS IN RUMINANTS |
JP5752359B2 (ja) * | 2010-02-25 | 2015-07-22 | 富士フイルム株式会社 | 体重増加抑制組成物及びこれを含む食品 |
JP5769710B2 (ja) * | 2010-07-22 | 2015-08-26 | ビオフェルミン製薬株式会社 | 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤 |
WO2013133685A1 (en) | 2012-03-09 | 2013-09-12 | Biotropics Malaysia Berhad | Extract formulations of rhodamnia cinerea and uses thereof |
GB2507254A (en) * | 2012-09-13 | 2014-04-30 | Ajit Ramanial Patel | Composition for reducing the consumption of food and the absorption of carbohydrate constituents thereof |
US11096978B2 (en) | 2018-01-12 | 2021-08-24 | Mellitas Health Foods, LLC | Common bean (phaseolus vulgaris) extract with high a-amylase inhibitory activity and low hemagglutinin activity |
GB201811312D0 (en) * | 2018-07-10 | 2018-08-29 | Nuchido Ltd | Compositions |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950319A (en) * | 1970-01-29 | 1976-04-13 | Farbenfabriken Bayer Aktiengesellschaft | Amylase inhibitor from wheat gluten using alcohol |
US3934006A (en) * | 1972-03-01 | 1976-01-20 | Bayer Aktiengesellschaft | Pharmaceutical compositions comprising saccharase inhibitors |
US4010258A (en) * | 1974-03-15 | 1977-03-01 | Ajinomoto Co., Inc. | Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus |
JP2757405B2 (ja) * | 1988-12-09 | 1998-05-25 | 日清製粉株式会社 | 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤 |
US5629023A (en) * | 1991-12-31 | 1997-05-13 | Bland; Jeffrey S. | Medical food composition for metabolic detoxification |
US5322697A (en) * | 1992-05-28 | 1994-06-21 | Meyer James H | Composition and method for inducing satiety |
CA2128044C (en) * | 1993-08-05 | 2007-02-20 | Klaus-Dieter Bremer | Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
JPH092963A (ja) | 1995-06-20 | 1997-01-07 | Yakult Honsha Co Ltd | マオウより得られる糖質分解酵素阻害物質及びそれを含有するダイエット食品 |
EP0796915A3 (de) * | 1996-03-22 | 1999-04-14 | Bayer Ag | Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen |
ID21411A (id) * | 1997-12-10 | 1999-06-10 | Takeda Chemical Industries Ltd | Agen untuk mengobati daya tahan glukosa yang berisiko tinggi rusak |
WO2000012109A1 (en) * | 1998-08-26 | 2000-03-09 | The Nippon Synthetic Chemical Industry Co., Ltd. | α-GLUCOSIDASE INHIBITOR |
WO2000012080A1 (en) * | 1998-09-01 | 2000-03-09 | Amway Corporation | Diet composition and method of weight management |
US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
JP2000186044A (ja) | 1998-12-22 | 2000-07-04 | Showa Sangyo Co Ltd | 糖質分解酵素阻害剤及びそれを含有する食品又は医薬品 |
KR20010101594A (ko) * | 1999-01-22 | 2001-11-14 | 훈자 디 마리아 카르멜라 마라찌타 에스.아.에스. | 지단백질 복합체 및 이를 함유하는 조성물 |
JP3106131B1 (ja) * | 1999-08-19 | 2000-11-06 | あづま食品株式会社 | ペースト状納豆及びその製造方法 |
GB9921229D0 (en) | 1999-09-08 | 1999-11-10 | Med Eq As | Compositions |
US6399101B1 (en) * | 2000-03-30 | 2002-06-04 | Mova Pharmaceutical Corp. | Stable thyroid hormone preparations and method of making same |
ATE343391T1 (de) * | 2000-05-24 | 2006-11-15 | Pfizer | Behandlung von pansenacidose mit amylasehemmern |
US20030004215A1 (en) * | 2001-06-15 | 2003-01-02 | Van Laere Katrien Maria Jozefa | Dietetic preparation and method for inhibiting intestinal carbohydrate absorption |
US6797287B2 (en) * | 2001-09-25 | 2004-09-28 | Pharmachem Laboratories, Inc. | Phaseolamin compositions and methods for using the same |
US20030082168A1 (en) * | 2001-10-22 | 2003-05-01 | Inna Yegorova | Compositions and methods for facilitating weight loss |
US20040018990A1 (en) * | 2002-07-25 | 2004-01-29 | Harvey Rosner | Treatment of obesity |
-
2002
- 2002-11-07 US US10/290,079 patent/US7108869B2/en not_active Expired - Lifetime
-
2003
- 2003-06-27 JP JP2003184272A patent/JP3793764B2/ja not_active Expired - Lifetime
- 2003-11-06 KR KR1020030078232A patent/KR100567717B1/ko active IP Right Grant
- 2003-11-06 CN CNB200310103807XA patent/CN100352504C/zh not_active Expired - Lifetime
-
2005
- 2005-05-18 US US11/131,538 patent/US7354606B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2004154126A (ja) | 2004-06-03 |
CN100352504C (zh) | 2007-12-05 |
US20040091554A1 (en) | 2004-05-13 |
CN1498659A (zh) | 2004-05-26 |
US7354606B2 (en) | 2008-04-08 |
JP3793764B2 (ja) | 2006-07-05 |
US20050208161A1 (en) | 2005-09-22 |
KR20040041026A (ko) | 2004-05-13 |
US7108869B2 (en) | 2006-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7354606B2 (en) | Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors | |
JP2007330124A (ja) | 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物 | |
US20030004215A1 (en) | Dietetic preparation and method for inhibiting intestinal carbohydrate absorption | |
US20090214511A1 (en) | Digestible compositions of inulin for managing blood glucose levels | |
CN108420854B (zh) | 提高耐力表现的抗疲劳组合物 | |
US7537790B2 (en) | Method and composition for reducing body weight and improving control of body lipids | |
JP2009077696A (ja) | サラシア属植物の抽出物とフラボノイドを含有する食品 | |
JP6228250B2 (ja) | 多糖消化阻害剤 | |
CA3001472A1 (en) | Composition comprising lactobacillus plantarum 2830 (ecgc 13110402) | |
JP2004105157A (ja) | 糖類分解酵素阻害飲食組成物 | |
KR20200023576A (ko) | 발효 흰점박이꽃무지 유충 추출물을 유효성분으로 함유하는 간 기능 개선용 조성물 | |
CN101020047B (zh) | 一种含有钙强化剂的保健食品 | |
JP2008074734A (ja) | インスリン抵抗性改善剤 | |
JP2006020606A (ja) | 肥満防止、改善のための健康食品用組成物 | |
JP2016040314A (ja) | 経口用医薬組成物および機能性食品 | |
JP2006016340A (ja) | ザクロ抽出物を有効成分とする、血中尿酸値低下剤 | |
US20040018990A1 (en) | Treatment of obesity | |
JP7296623B2 (ja) | α-アミラーゼ活性阻害剤及びα-アミラーゼ活性阻害剤の製造方法 | |
JP2004256522A (ja) | 糖尿病予防・治療用組成物 | |
US20040122054A1 (en) | Alpha glucosidase inhibitor use | |
KR102575452B1 (ko) | 간 기능 개선 활성을 갖는 균주 및 이의 용도 | |
JP2009298759A (ja) | α‐アミラーゼ阻害剤 | |
KR102043461B1 (ko) | 아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물 | |
JP2012162472A (ja) | 脂質排泄促進剤 | |
JP5798544B2 (ja) | サラシア属植物の抽出物とフラボノイドを含有する食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130227 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140227 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150227 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161229 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171228 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20181227 Year of fee payment: 14 |